Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction

References

• Castagno D, Skali H, Takeuchi M, et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure. J Am Coll Cardiol. 2012;59(20):1785–1795. doi: 10.1016/j.jacc.2011.12.044.
   PubMed Web of Science ®Google Scholar
• Lan WR, Lin SI, Liao FC, et al. Effect of reducing heart rate on outcomes in patients with reduced ejection fraction. Am J Cardiol. 2021;150:77–81. doi: 10.1016/j.amjcard.2021.03.050.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875–885. doi: 10.1016/S0140-6736(10)61198-1.
   PubMed Web of Science ®Google Scholar
• Bristow MR, Altman NL. Heart rate in preserved ejection fraction heart failure. JACC Heart Fail. 2017;5(11):792–794. doi: 10.1016/j.jchf.2017.09.004.
   PubMed Web of Science ®Google Scholar
• Maeder MT, Kaye DM. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Int J Cardiol. 2012;155(2):249–256. doi: 10.1016/j.ijcard.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Van Essen BJ, Tromp J, Ter Maaten JM, et al. Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction. Eur J Heart Fail. 2023;25(1):35–42. doi: 10.1002/ejhf.2695.
   PubMed Web of Science ®Google Scholar
• Meyer M, LeWinter MM. Heart rate and heart failure with preserved ejection fraction: time to slow β-blocker use? Circ Heart Fail. 2019;12(8):e006213. doi: 10.1161/CIRCHEARTFAILURE.119.006213.
   PubMed Web of Science ®Google Scholar
• Rienstra M, Damman K, Mulder BA, et al. Beta-blockers and outcome in heart failure and atrial fibrillation. JACC Heart Fail. 2013;1(1):21–28. doi: 10.1016/j.jchf.2012.09.002.
   PubMed Web of Science ®Google Scholar
• Kotecha D, Flather MD, Altman DG, et al. Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol. 2017;69(24):2885–2896. doi: 10.1016/j.jacc.2017.04.001.
   PubMed Web of Science ®Google Scholar
• Vazir A, Claggett B, Pitt B, et al. Prognostic importance of temporal changes in resting heart rate in heart failure and preserved ejection fraction. JACC Heart Fail. 2017;5(11):782–791. doi: 10.1016/j.jchf.2017.08.018.
   PubMed Web of Science ®Google Scholar
• Silverman DM, Plante TB, Infeld M, et al. Association of β-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT trial. JAMA Netw Open. 2019;2(12):e1916598. doi: 10.1001/jamanetworkopen.2019.16598.
   PubMed Web of Science ®Google Scholar
• Arnold SV, Silverman DN, Gosch K, et al. Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction. JACC Heart Fail. 2023;11(8 Pt 1):893–900. doi: 10.1016/j.jchf.2023.03.017.
   PubMed Web of Science ®Google Scholar
• Oliva F, Sormani P, Contri R, et al. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure. Int J Cardiol. 2018;253:97–104. doi: 10.1016/j.ijcard.2017.09.191.
   PubMed Web of Science ®Google Scholar
• Wang J, Fang F, Yip GWK, et al. Importance of chronotropic response and left ventricular long-axis function for exercise performance in patients with heart failure and preserved ejection fraction. Int J Cardiol. 2016;202:339–343. doi: 10.1016/j.ijcard.2015.09.029.
   PubMed Web of Science ®Google Scholar
• Zweerink A, Van Der Lingen ALCJ, Handoko ML, et al. Chronotropic incompetence in chronic heart failure: a state-of-the-art review. Circ Heart Fail. 2018;11(8):e004969. doi: 10.1161/CIRCHEARTFAILURE.118.004969.
   PubMed Web of Science ®Google Scholar
• Sanders P, Kistler PM, Morton JB, et al. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation. 2004;110(8):897–903. doi: 10.1161/01.CIR.0000139336.69955.AB.
   PubMed Web of Science ®Google Scholar
• Messias LR, Messias ACNV, De Miranda SMR, et al. Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction. Int J Cardiol. 2016;203:900–902. doi: 10.1016/j.ijcard.2015.10.224.
   PubMed Web of Science ®Google Scholar
• Mesquita T, Zhang R, Cho JH, et al. Mechanisms of sinoatrial node dysfunction in heart failure with preserved ejection fraction. Circulation. 2022;145(1):45–60. doi: 10.1161/CIRCULATIONAHA.121.054976.
   PubMed Web of Science ®Google Scholar
• Domínguez E, Palau P, Núñez E, et al. Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction. ESC Heart Fail. 2018;5(4):579–585. doi: 10.1002/ehf2.12281.
   PubMed Web of Science ®Google Scholar
• Magrì D, Corrà U, Di Lenarda A, et al. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria: cardiovascular mortality and chronotropic incompetence. Eur J Heart Fail. 2014;16(2):201–209. doi: 10.1002/ejhf.36.
   PubMed Web of Science ®Google Scholar
• Benes J, Kotrc M, Borlaug BA, et al. Resting heart rate and heart rate reserve in advanced heart failure have distinct pathophysiologic correlates and prognostic impact. JACC Heart Fail. 2013;1(3):259–266. doi: 10.1016/j.jchf.2013.03.008.
   PubMed Web of Science ®Google Scholar
• Shah S, Segar MW, Kondamudi N, et al. Supranormal left ventricular ejection fraction, stroke volume, and cardiovascular risk. JACC: Heart Fail. 2022;10(8):583–594. doi: 10.1016/j.jchf.2022.05.007.
   PubMed Web of Science ®Google Scholar
• Wehner GJ, Jing L, Haggerty CM, et al. Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Eur Heart J. 2020;41(12):1249–1257. doi: 10.1093/eurheartj/ehz550.
   PubMed Web of Science ®Google Scholar
• Abidov A, Hachamovitch R, Hayes SW, et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation. 2003;107(23):2894–2899. doi: 10.1161/01.CIR.0000072770.27332.75.
   PubMed Web of Science ®Google Scholar
• Palau P, Seller J, Domínguez E, et al. Effect of β-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. J Am Coll Cardiol. 2021;78(21):2042–2056. doi: 10.1016/j.jacc.2021.08.073.
   PubMed Web of Science ®Google Scholar
• Reddy YNV, Koepp KE, Carter R, et al. Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial. JAMA. 2023;329(10):801–809. doi: 10.1001/jama.2023.0675.
   PubMed Web of Science ®Google Scholar